[Modifications of sialylation in BHK 21/C13 cells after in vitro transfection by c-Ha-ras human oncogene]. 1991

H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
Université des Sciences et Techniques de Lille Flandres-Artois, Unité mixte de Recherches du C.N.R.S. n.111, Villeneuve-d'Ascq.

A Hamster kidney fibroblast cell line (BHK 21/C13) has been transfected by c-Ha-ras human oncogene. The expression of the oncogene significantly modified the global sialytransferase activity of the cell extract. This activity is enhanced on an average 2.5 fold whatever the acceptor. In addition, the proportion of cell-surface associated N-glycolylneuraminic acid is enhanced in transfectants, the ratio N-acetylneuraminic acid/N-glycolylneuraminic acid decreases from 7.10 to 2.80. These results suggest that a tight relationship exists, in c-Ha-ras transfected BHK cells, between the expression of the oncogene and the neuraminic acid metabolism as well as a gene regulation of glycoconjugate sialylation.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012794 Sialic Acids A group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues. N-Acetylneuraminic Acids,Acids, N-Acetylneuraminic,Acids, Sialic,N Acetylneuraminic Acids
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D016283 Proto-Oncogene Proteins p21(ras) Cellular proteins encoded by the H-ras, K-ras and N-ras genes. The proteins have GTPase activity and are involved in signal transduction as monomeric GTP-binding proteins. Elevated levels of p21 c-ras have been associated with neoplasia. This enzyme was formerly listed as EC 3.6.1.47. Proto-Oncogene Proteins c-ras,c-Ha-ras p21,c-Ki-ras p21,p21(N-ras),p21(c-Ha-ras),p21(c-Ki-ras),p21(c-ras),p21(ras),ras Proto-Oncogene Protein p21,Proto-Oncogene Protein p21(c-Ha-ras),Proto-Oncogene Protein p21(c-Ki-ras),Proto-Oncogene Protein p21(c-N-ras),Proto-Oncogene Protein p21(ras),Proto-Oncogene Protein ras,c-ras Proteins,p21 c-H-ras,p21 c-Ha-ras,p21 c-K-ras,p21 c-Ki-ras,p21 c-ras,ras Proto-Oncogene Product p21,Proteins c-ras, Proto-Oncogene,Proto Oncogene Protein ras,Proto Oncogene Proteins c ras,c Ha ras p21,c Ki ras p21,c ras Proteins,c-H-ras, p21,c-Ha-ras, p21,c-K-ras, p21,c-Ki-ras, p21,c-ras, Proto-Oncogene Proteins,c-ras, p21,p21 c H ras,p21 c Ha ras,p21 c K ras,p21 c Ki ras,p21 c ras,p21, c-Ha-ras,p21, c-Ki-ras,ras Proto Oncogene Product p21,ras Proto Oncogene Protein p21,ras, Proto-Oncogene Protein

Related Publications

H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
November 1991, Oncogene,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
January 1991, Molecular carcinogenesis,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
May 1989, The Biochemical journal,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
February 1979, The Biochemical journal,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
February 1994, Journal of cell science,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
March 1973, The Biochemical journal,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
September 1974, FEBS letters,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
January 1995, Anticancer research,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
October 1990, Biochemical pharmacology,
H Cazlaris, and N Le Marer, and V Laudet, and C Lagrou, and Q Zhu, and P Delannoy, and J Montreuil
November 1997, Acta radiologica (Stockholm, Sweden : 1987),
Copied contents to your clipboard!